chr11-64791918-T-G

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_004579.5(MAP4K2):ā€‹c.2083A>Cā€‹(p.Ile695Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000101 in 1,590,408 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: š‘“ 0.000020 ( 0 hom., cov: 33)
Exomes š‘“: 0.0000090 ( 0 hom. )

Consequence

MAP4K2
NM_004579.5 missense

Scores

1
18

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.127
Variant links:
Genes affected
MAP4K2 (HGNC:6864): (mitogen-activated protein kinase kinase kinase kinase 2) The protein encoded by this gene is a member of the serine/threonine protein kinase family. Although this kinase is found in many tissues, its expression in lymphoid follicles is restricted to the cells of germinal centre, where it may participate in B-cell differentiation. This kinase can be activated by TNF-alpha, and has been shown to specifically activate MAP kinases. This kinase is also found to interact with TNF receptor-associated factor 2 (TRAF2), which is involved in the activation of MAP3K1/MEKK1. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2015]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.03237486).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
MAP4K2NM_004579.5 linkuse as main transcriptc.2083A>C p.Ile695Leu missense_variant 27/32 ENST00000294066.7 NP_004570.2 Q12851-1A0A024R567
MAP4K2NM_001307990.2 linkuse as main transcriptc.2059A>C p.Ile687Leu missense_variant 27/32 NP_001294919.1 Q12851-2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
MAP4K2ENST00000294066.7 linkuse as main transcriptc.2083A>C p.Ile695Leu missense_variant 27/321 NM_004579.5 ENSP00000294066.2 Q12851-1

Frequencies

GnomAD3 genomes
AF:
0.0000197
AC:
3
AN:
152128
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000578
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000456
AC:
10
AN:
219228
Hom.:
0
AF XY:
0.0000586
AC XY:
7
AN XY:
119504
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000580
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000904
AC:
13
AN:
1438162
Hom.:
0
Cov.:
33
AF XY:
0.00000842
AC XY:
6
AN XY:
712488
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.000281
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.0000337
GnomAD4 genome
AF:
0.0000197
AC:
3
AN:
152246
Hom.:
0
Cov.:
33
AF XY:
0.0000134
AC XY:
1
AN XY:
74448
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.000580
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.0000189
ExAC
AF:
0.0000414
AC:
5

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsOct 03, 2023The c.2083A>C (p.I695L) alteration is located in exon 27 (coding exon 27) of the MAP4K2 gene. This alteration results from a A to C substitution at nucleotide position 2083, causing the isoleucine (I) at amino acid position 695 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.085
BayesDel_addAF
Benign
-0.52
T
BayesDel_noAF
Benign
-0.64
CADD
Benign
13
DANN
Benign
0.79
DEOGEN2
Benign
0.11
T;.
Eigen
Benign
-0.86
Eigen_PC
Benign
-0.66
FATHMM_MKL
Benign
0.54
D
LIST_S2
Benign
0.56
T;T
M_CAP
Benign
0.0048
T
MetaRNN
Benign
0.032
T;T
MetaSVM
Benign
-0.99
T
MutationAssessor
Benign
0.46
N;.
PrimateAI
Uncertain
0.53
T
PROVEAN
Benign
-0.33
N;N
REVEL
Benign
0.047
Sift
Benign
0.49
T;T
Sift4G
Benign
0.68
T;T
Polyphen
0.033
B;.
Vest4
0.20
MutPred
0.57
Gain of catalytic residue at I695 (P = 0.0044);.;
MVP
0.33
MPC
0.28
ClinPred
0.022
T
GERP RS
3.5
Varity_R
0.033
gMVP
0.20

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs559558840; hg19: chr11-64559390; API